Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

(4013)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 38 15061 950--
Entreprise Value (EV)1 38 15062 68764 12365 331
P/E ratio 36,1x50,1x46,2x44,9x
Yield 1,38%1,27%1,43%1,46%
Capitalization / Revenue 6,51x9,17x8,51x7,91x
EV / Revenue 6,51x9,28x8,81x8,34x
EV / EBITDA 26,6x37,4x32,8x31,1x
Price to Book 7,77x11,5x10,7x9,69x
Nbr of stocks (in thousands) 350 000350 000--
Reference price (SAR) 109177177177
Announcement Date 02/21/2021---
1 SAR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023
Net sales1 5 8626 7547 2777 831
EBITDA1 1 4331 6751 9552 099
Operating profit (EBIT)1 1 1151 3421 5271 607
Operating Margin 19,0%19,9%21,0%20,5%
Pre-Tax Profit (EBT)1 1 1281 3361 4631 546
Net income1 1 0551 2281 3811 417
Net margin 18,0%18,2%19,0%18,1%
EPS2 3,023,543,843,95
Dividend per Share2 1,502,252,532,59
Announcement Date 02/21/2021---
1 SAR in Million
2 SAR
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2
Net sales1 1 6911 6951 751
EBITDA ---
Operating profit (EBIT)1 -350340
Operating Margin -20,6%19,4%
Pre-Tax Profit (EBT) ---
Net income1 -319325
Net margin -18,8%18,6%
EPS2 -0,910,93
Dividend per Share ---
Announcement Date 02/21/202104/25/202108/08/2021
1 SAR in Million
2 SAR
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023
Net Debt1 -7372 1733 381
Net Cash position1 ----
Leverage (Debt / EBITDA) -0,44x1,11x1,61x
Free Cash Flow1 1 420-256-87,7-325
ROE (Net Profit / Equities) 22,7%24,0%25,0%23,7%
Shareholders' equity1 4 6535 1175 5235 986
ROA (Net Profit / Asset) 11,8%12,5%13,0%11,9%
Assets1 8 9749 82410 66211 905
Book Value Per Share2 14,015,416,518,3
Cash Flow per Share ----
Capex1 7581 5611 8822 278
Capex / Sales 12,9%23,1%25,9%29,1%
Announcement Date 02/21/2021---
1 SAR in Million
2 SAR
Key data
Capitalization (SAR) 61 950 000 000
Capitalization (USD) 16 514 715 291
Net sales (SAR) 5 861 605 000
Net sales (USD) 1 562 762 509
Free-Float 26,2%
Free-Float capitalization (SAR) 16 243 290 000
Free-Float capitalization (USD) 4 330 158 349
Avg. Exchange 20 sessions (SAR) 16 525 782
Avg. Exchange 20 sessions (USD) 4 405 939
Average Daily Capital Traded 0,03%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA